Mentions
Extended reach
Total likes
Video views
AI synopsis
Analysis shows strong agreement on SOX17's diagnostic potential, with expressions like 'game-changing' and 'more reliable marker' highlighting enthusiasm. The tone is optimistic and focused on clinical impact, as seen in mentions of improved specificity and sensitivity over traditional markers like PAX8, indicating high relevance and deep interest in the findings.
Most participants agree that the study introduces a promising and more precise biomarker for ovarian and endometrial cancers.
Discussions reflect high curiosity and enthusiasm, with many emphasizing potential clinical benefits.
Comments frequently reference specific markers and comparisons to existing methods, indicating active engagement.
There is consensus that the findings could significantly influence diagnostic practices and future research.
SOX17: A Highly Sensitive and Specific Immunomarker for Ovarian and En... https://t.co/gzILggiDX2
SOX17: A Highly Sensitive and Specific Immunomarker for Ovarian and Endometrial Carcinomas - https://t.co/etideycHpb #ScholarAlerts
Currently PAX8 is the most commonly used immunomarker for gynecologic carcinomas, but it lacks specificity. This study identifies SOX17 as a more specific marker with high expression in ovarian and endometrial cancers…
SOX17 shows high sensitivity and specificity for ovarian and endometrial carcinomas, outperforming PAX8 in certain subtypes. It is highly expressed in these tumors and not in thyroid, renal, and mesothelioma, making it…
SOX17: A Highly Sensitive and Specific Immunomarker for Ovarian and En... https://t.co/gzILggiDX2
SOX17: A Highly Sensitive and Specific Immunomarker for Ovarian and Endometrial Carcinomas - https://t.co/etideycHpb #ScholarAlerts
Mod Pathol. 2022;41(12):1767‐1779. doi:10.1038/s41388‐022‐02210‐3 2023;36(2):100001. doi:10.1016/j.modpat.2022.100001 11. Chaves‐Moreira D, Mitchell MA ...
RM
SM